Related Experiment Video
Updated: Jan 10, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Ceftazidime-Avibactam Resistance in Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections: Risk Factors
1Department of Enfectious Disease, Erzurum Regional Training and Research Hospital, 25070 Erzurum, Türkiye.
Background/Introduction:
Carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteremia is a serious public health problem due to its high mortality rate and limited treatment options. This study aimed to identify risk factors associated with ceftazidime-avibactam (CAZ-AVI) resistance in CRKP bacteremia and to evaluate its impact on clinical outcomes.
Methods:
This retrospective single-center cohort study included adult patients with CRKP bloodstream infections treated at a tertiary hospital in Türkiye between January 2021 and December 2024. Demographic, clinical, and laboratory data were collected, and risk factors for CAZ-AVI resistance and 30-day mortality were analyzed.
Results:
Among 154 patients, 42.8% had CAZ-AVI-resistant strains. Resistant infections were associated with longer hospital stays and higher Charlson Comorbidity Index (CCI) scores. The resistance rate was lower in patients with intra-abdominal infections, while fluoroquinolone and fosfomycin use was more common in the resistant group. The overall 30-day mortality rate was 57%. Pitt bacteremia score and creatinine levels were identified as independent predictors of mortality.
Discussion:
CAZ-AVI resistance in CRKP bacteremia appears to develop in patients with prolonged hospitalization and high comorbidity burden. These factors likely increase exposure to resistant microorganisms and antibiotic pressure, complicating treatment outcomes.
Conclusions:
CAZ-AVI resistance in CRKP bacteremia is associated with specific clinical risk profiles and contributes to high mortality. Identifying high-risk patients and optimizing antimicrobial stewardship are essential to improve prognosis.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Related Concept Videos
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Estimation of k and VD of Aminoglycosides